Merck & Co.
Search results
For 175 years, Pfizer has been a trusted partner in healthcare – discovering, developing, and delivering medical breakthroughs to prevent, treat, and cure some of the world’s most vexing conditions and diseases. Learn more about our history.
Homepage | Pfizer Singapore. Science Contact Us. Breakthroughs that Change Patients' Lives Pfizer Colleagues Work to Challenge the Mos t Feared Diseases of Our Time Learn More Coronavirus Resources Current information on our scientific progress Learn More Innovative Therapies for Tomorrow Translating advanced science and technologies into ...
Pfizer Inc. (/ ˈ f aɪ z ər / FY-zər) is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).
We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our portfolio of medicines for therapeutic areas include vaccines, oncology, cardiovascular diseases, infectious diseases, immunological disorders, rare diseases and mental health.
At Pfizer, we have a long tradition of collaborating with external parties to advance medical breakthroughs. Discover our latest breakthroughs
Pfizer Inc. and BioNTech SE today announced positive topline results from a Phase 1/2 study (NCT05596734) evaluating the safety, tolerability and immunogenicity of mRNA-based combination vaccine candidates for influenza and COVID-19 among healthy adults 18 to 64 years of age. 10.13.2023
The vaccine reduces the risks of infection and severe disease from COVID-19, and has good protection against the current virus variants. For persons aged 6 months and above, the primary series of the vaccine consists of 2 doses taken at the recommended interval of 8 weeks or at least 21 days apart.
Jun 25, 2022 · Omicron-adapted monovalent candidate given as a fourth booster dose elicited a 13.5 and 19.6-fold increase in neutralizing geometric titers against Omicron BA.1 at 30 µg and 60 µg dose levels; bivalent vaccine candidate exhibited a 9.1 and 10.9-fold increase against Omicron Geometric mean ratios for Omicron neutralizing antibody response ...
Dec 14, 2020 · 4 The Pfizer-BioNTech COVID-19 vaccine was granted interim authorisation under the Pandemic Special Access Route (PSAR). This regulatory pathway facilitates access to critical novel vaccines, medicines and medical devices during a pandemic such as the current COVID-19 pandemic.
Aug 23, 2021 · FDA approved the first COVID-19 vaccine, which has been known as the Pfizer-BioNTech COVID-19 Vaccine, and is now marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease...
